Vi antigen from Salmonella typhosa and immunity against typhoid fever. 11. Safety and antigenicity in humans.

Safety and antigenicity of a purified preparation of Salmonella typhosa Vi antigen was evaluated in human volunteers. Dosages of Vi antigen at 25, 50, and 100 mug were less toxic than U.S. standard typhoid vaccine (lot 6A) containing 5 X 10(8) bacteria per dosage. Vi antigen in comparison with the s...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Infect Immun
Principais autores:	Levin, D M, Wong, K H, Reynolds, H Y, Sutton, A, Northrup, R S
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1975
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC415434/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/54336/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.12.6.1290-1294.1975
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!